SCHEMBL6977065

SCHEMBL6977065

CCOC(=O)c1cc2cc(Cl)cc([N+](=O)[O-])c2o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.47
MAPT P10636 4/20 0.43
LMNA P02545 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 4/20 0.41
POLB P06746 3/20 0.41
GALR2 O43603 1/20 0.41
MITF O75030 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HPGD P15428 1/20 0.41
XBP1 P17861 1/20 0.41
CCR6 P51684 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PDE7A Q13946 1/20 0.41
KCNMA1 Q12791 1/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1982581 0.85 GPR35 (0.53) MAOBMAPTLMNANPSR1TDP1
SCHEMBL29852905 0.85 GPR35 (0.53) MAOBMAPTLMNANPSR1TDP1
SCHEMBL6448421 0.84 MAPT (0.47) MAOBMAPTLMNANPSR1KMT2A
SCHEMBL9612675 0.82 MAOB (0.52) MAOBMAPTKMT2AMEN1ALDH1A1
SCHEMBL6635123 0.82 MAOA (0.48) MAOBMAPTLMNANPSR1KMT2A
SCHEMBL26688263 0.81 MAPT (0.53) MAOBMAPTTDP1ALDH1A1POLB
SCHEMBL31651569 0.80 MAOB (0.70) MAOBALDH1A1GAAKDM4E
Hydrochloric Acid SCHEMBL6981376 0.79 MAOB (0.49) MAOBMAPTLMNANPSR1KMT2A
SCHEMBL7829557 0.79 GPR35 (0.38) MAOBMAPTLMNATDP1KMT2A
SCHEMBL6979379 0.78 MAPT (0.55) MAPTKMT2AMEN1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 MAOB 2164/4885MAPT 4824/4885LMNA 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.